To assess the anti-tumor activity of LV-SM7L, we transduced U87MG (high IL-20Rα/β, Fig. S1) or H4 (low IL-20Rα/β) human GBM cells with LV-SM7L, LV-M7 or control. This evidence concerns the gene IL20RA and neoplasm.